Pali Research upgrades CME Group (NYSE: CME) from Sell to Neutral.

Pali analyst says, "We are upgrading CME to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE